Analysen zu Novartis AG
| 23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | Novartis Buy | Deutsche Bank AG | |
| 10.04.24 | Novartis Buy | UBS AG | |
| 04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 28.03.24 | Novartis Underweight | Barclays Capital | |
| 25.03.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.03.24 | Novartis Buy | Deutsche Bank AG | |
| 07.02.24 | Novartis Buy | Deutsche Bank AG | |
| 07.02.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 06.02.24 | Novartis Underweight | Barclays Capital | |
| 06.02.24 | Novartis Buy | UBS AG | |
| 05.02.24 | Novartis Buy | Jefferies & Company Inc. | |
| 02.02.24 | Novartis Buy | Deutsche Bank AG | |
| 31.01.24 | Novartis Kaufen | DZ BANK | |
| 31.01.24 | Novartis Buy | UBS AG | |
| 31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 30.01.24 | Novartis Buy | UBS AG | |
| 16.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 15.01.24 | Novartis Buy | UBS AG | |
| 09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Novartis Neutral | UBS AG | |
| 05.01.24 | Novartis Buy | Deutsche Bank AG | |
| 03.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 21.12.23 | Novartis Underweight | Barclays Capital | |
| 19.12.23 | Novartis Buy | Deutsche Bank AG | |
| 05.12.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.11.23 | Novartis Buy | Deutsche Bank AG | |
| 29.11.23 | Novartis Underweight | Barclays Capital | |
| 28.11.23 | Novartis Neutral | UBS AG | |
| 28.11.23 | Novartis Buy | Jefferies & Company Inc. | |
| 27.11.23 | Novartis Buy | Deutsche Bank AG | |
| 26.10.23 | Novartis Buy | Deutsche Bank AG | |
| 24.10.23 | Novartis Neutral | UBS AG | |
| 24.10.23 | Novartis Buy | Jefferies & Company Inc. | |
| 23.10.23 | Novartis Underweight | Barclays Capital | |
| 19.10.23 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.10.23 | Novartis Buy | Jefferies & Company Inc. | |
| 05.10.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.10.23 | Novartis Buy | Deutsche Bank AG | |
| 04.10.23 | Novartis Neutral | UBS AG | |
| 04.10.23 | Novartis Buy | Deutsche Bank AG | |
| 03.10.23 | Novartis Buy | Deutsche Bank AG | |
| 26.09.23 | Novartis Buy | Deutsche Bank AG | |
| 25.09.23 | Novartis Equal-weight | Morgan Stanley | |
| 22.09.23 | Novartis Buy | Deutsche Bank AG |
Aktuelle Aktienanalysen
| 27.05.25 | Carl Zeiss Meditec Sector Perform | RBC Capital Markets | |
| 27.05.25 | Bayer Equal Weight | Barclays Capital | |
| 27.05.25 | Salesforce Neutral | UBS AG | |
| 27.05.25 | Brenntag Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.25 | Symrise Hold | Jefferies & Company Inc. | |
| 27.05.25 | Nestlé Underperform | Jefferies & Company Inc. | |
| 26.05.25 | Brenntag Neutral | UBS AG | |
| 26.05.25 | Linde Neutral | UBS AG | |
| 26.05.25 | Fresenius Medical Care Neutral | UBS AG | |
| 26.05.25 | Air Liquide Buy | UBS AG | |
| 26.05.25 | Symrise Buy | UBS AG | |
| 26.05.25 | Givaudan Neutral | UBS AG | |
| 26.05.25 | Fresenius Buy | UBS AG | |
| 26.05.25 | WACKER CHEMIE Buy | UBS AG | |
| 26.05.25 | LANXESS Neutral | UBS AG | |
| 26.05.25 | Evonik Neutral | UBS AG | |
| 26.05.25 | Covestro Neutral | UBS AG | |
| 26.05.25 | BASF Neutral | UBS AG | |
| 26.05.25 | Akzo Nobel Buy | UBS AG | |
| 26.05.25 | K+S Sell | UBS AG | |
| 26.05.25 | Bayer Neutral | UBS AG | |
| 26.05.25 | Philips Buy | UBS AG | |
| 26.05.25 | Siemens Healthineers Neutral | UBS AG | |
| 26.05.25 | Carl Zeiss Meditec Neutral | UBS AG | |
| 26.05.25 | DocMorris Buy | Jefferies & Company Inc. | |
| 26.05.25 | Redcare Pharmacy Buy | Jefferies & Company Inc. | |
| 26.05.25 | CANCOM Hold | Jefferies & Company Inc. | |
| 26.05.25 | flatexDEGIRO Hold | Jefferies & Company Inc. | |
| 26.05.25 | Vossloh Buy | Jefferies & Company Inc. | |
| 26.05.25 | Kontron Buy | Jefferies & Company Inc. | |
| 26.05.25 | Wacker Neuson Hold | Jefferies & Company Inc. | |
| 26.05.25 | FRIEDRICH VORWERK Hold | Jefferies & Company Inc. | |
| 26.05.25 | Nagarro Buy | Jefferies & Company Inc. | |
| 26.05.25 | Befesa Buy | Jefferies & Company Inc. | |
| 26.05.25 | Bechtle Buy | Jefferies & Company Inc. | |
| 26.05.25 | Dürr Outperform | Bernstein Research | |
| 26.05.25 | CTS Eventim Halten | DZ BANK | |
| 26.05.25 | Frequentis accumulate | Erste Group Bank | |
| 26.05.25 | K+S Hold | Warburg Research | |
| 26.05.25 | easyJet Overweight | JP Morgan Chase & Co. | |
| 26.05.25 | Mercedes-Benz Group Hold | Jefferies & Company Inc. | |
| 26.05.25 | Boeing Buy | UBS AG | |
| 23.05.25 | ProSiebenSat.1 Media Neutral | JP Morgan Chase & Co. | |
| 23.05.25 | RWE Buy | Jefferies & Company Inc. | |
| 23.05.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 23.05.25 | ATOSS Software Hold | Jefferies & Company Inc. | |
| 23.05.25 | Apple Neutral | UBS AG | |
| 23.05.25 | Evonik Kaufen | DZ BANK | |
| 23.05.25 | HENSOLDT Underperform | Jefferies & Company Inc. | |
| 23.05.25 | Salzgitter Hold | Jefferies & Company Inc. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.